Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States

Rebecca L Robinson, Thomas J Schnitzer, Sophie Barlow, Mia Berry, Andrew G Bushmakin, Joseph C Cappelleri, Leslie Tive, Jessica Jackson, James Jackson, Lars Viktrup, Rebecca L Robinson, Thomas J Schnitzer, Sophie Barlow, Mia Berry, Andrew G Bushmakin, Joseph C Cappelleri, Leslie Tive, Jessica Jackson, James Jackson, Lars Viktrup

Abstract

Introduction: Satisfaction with medications prescribed for osteoarthritis (OA) varies; this study aimed to determine the factors associated with satisfaction in US patients and their physicians.

Methods: This point-in-time study used the Adelphi OA Disease Specific Programme (physicians identified from public lists reported on nine consecutive patients diagnosed with OA [any joint]: physicians and patients completed questionnaires). Patient's demographic, clinical, and treatment characteristics associated with patient-reported and physician-rated overall satisfaction with, and expectations of effectiveness of, medication for OA were assessed using multivariate linear regression.

Results: Responses from 572 patients (mean age 64.9 years, 60.5% female) currently prescribed medication for OA and 153 physicians (81 primary care, 35 rheumatologists, 37 orthopedic surgeons) were analyzed. Pain intensity was moderate or severe for 59.4% of patients. Greater patient-reported overall satisfaction with medication was significantly associated with (standardized beta, 95% confidence interval) exercise (0.12, 0.03-0.20), comorbid other musculoskeletal or painful conditions (vs none) (0.15, 0.06-0.24), and physicians' report that the best control had been achieved (0.12, 0.03-0.20); lack of efficacy was among factors associated with worse satisfaction. Greater patient-reported expectation of effectiveness was significantly associated with exercise (0.12, 0.03-0.21) and the most troublesome joint not being a knee, hip, or their back (0.08, 0.01-0.14). Greater physician-rated overall satisfaction with medication was significantly associated with their report that the best control had been achieved (0.18, 0.11-0.26), the most troublesome joint being a knee (0.08, 0.01-0.14), comorbid other musculoskeletal or painful conditions (0.07, 0.01-0.12), obesity (0.06, 0.00-0.11), and female patients (0.06, 0.00-0.11); lack of efficacy and adverse events/tolerability issues were among factors associated with worse satisfaction. For physicians, their report that the best control had been achieved (0.19, 0.11-0.27), the most troublesome joint being a knee (0.08, 0.00-0.15), improving (vs stable) OA (0.15, 0.07-0.24), and uncertain duration of OA (0.11, 0.02-0.21) were associated with greater perception that the medication was meeting patients' efficacy expectations.

Conclusion: Although efficacy was strongly associated with both patients' and physicians' satisfaction with medication, other factors were also important, including exercise (for patients), tolerability (for physicians), and knee OA (for physicians).

Keywords: Analgesics; Patient satisfaction; Prescription analgesic medication; Real-world clinical practice; Treatment satisfaction.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Patient-reported a overall satisfaction witha, and b expectations of effectiveness ofb, currently prescribed medication for OA. a Patients were asked “Which of the following options best describes your overall satisfaction with the prescribed medicine(s) for your osteoarthritis?” (options: very satisfied, 1; somewhat satisfied, 2; neither satisfied nor dissatisfied, 3; somewhat dissatisfied, 4; very dissatisfied, 5). Sample size: n = 572. b Patients were asked “How is your current medicine(s) meeting your level of expectation in relation to how effective it is for your OA?” (options: it is a great deal more effective than I expected, 1; it is more effective than I expected, 2; it matches my expectations, 3; it is less effective than I expected, 4; it is much less effective than I expected, 5). Sample size: n = 557. OA osteoarthritis
Fig. 2
Fig. 2
Patient-reported satisfaction with attributes of currently prescribed medication for OA. Patients rated their satisfaction with different attributes of medications from 1 to 5 (extremely dissatisfied, 1; somewhat dissatisfied, 2; neither dissatisfied nor satisfied, 3; somewhat satisfied, 4; extremely satisfied, 5), in response to “How satisfied are you with your prescribed medicine(s) in relation to…”: provides short-term pain relief (sample size for this response, n = 552), provides long lasting pain relief (n = 554), eases your pain quickly (n = 554), helps keep you mobile and active (n = 550), allows you to return to your usual activities (n = 552), helps maintain your independence (n = 552), the side effects of the medicine (n = 551), has clear and simple instructions (n = 549), is convenient to take in terms of fitting into your schedule (n = 551), is easy to remember to take (n = 551), the cost of my medicine (n = 552). OA osteoarthritis
Fig. 3
Fig. 3
Physician-rated a overall satisfaction with currently prescribed medication for OAa and b views of how the currently prescribed medication for OA is meeting the patient’s expectation of efficacyb. a Physicians were asked “Which of the following statements best describes your satisfaction with the patient’s prescribed therapy (to treat their OA pain)?” (options: very satisfied, 1; somewhat satisfied, 2; neither satisfied nor dissatisfied, 3; somewhat dissatisfied, 4; very dissatisfied, 5). Sample size: physician ratings for 572 patients. b Physicians were asked “How do you believe the current drug therapy regimen meets the patient’s own expectations in relation to efficacy achieved?” (options: greatly exceeds expectations, 1; exceeds expectations, 2; matches expectations, 3; less than expected, 4; much less than expected, 5). Sample size: physician ratings for 572 patients. OA osteoarthritis

References

    1. Paskins Z, Sanders T, Hassell AB. Comparison of patient experiences of the osteoarthritis consultation with GP attitudes and beliefs to OA: a narrative review. BMC Fam Pract. 2014;15:46. doi: 10.1186/1471-2296-15-46.
    1. Geenen R, Overman CL, Christensen R, et al. EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77:797–807.
    1. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27:1578–1589. doi: 10.1016/j.joca.2019.06.011.
    1. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020;72:149–162. doi: 10.1002/acr.24131.
    1. Ueda K, Sasaki N, Goren A, et al. Treatment satisfaction with pharmaceutical interventions in Japanese adults with osteoarthritis and chronic knee pain: an analysis of a web-based survey. Clin Interv Aging. 2018;13:2179–2191. doi: 10.2147/CIA.S176289.
    1. Van Zaanen Y, Hoorntje A, Koenraadt KLM, et al. Non-surgical treatment before hip and knee arthroplasty remains underutilized with low satisfaction regarding performance of work, sports, and leisure activities. Acta Orthop. 2020;91:717–723. doi: 10.1080/17453674.2020.1813440.
    1. Taylor SD, Everett SV, Taylor TN, Watson DJ, Taylor-Stokes G. A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control. Open Access Rheumatol. 2013;5:69–76. doi: 10.2147/OARRR.S41940.
    1. Carlson J, Youngblood R, Dalton JA, Blau W, Lindley C. Is patient satisfaction a legitimate outcome of pain management? J Pain Symptom Manage. 2003;25:264–275. doi: 10.1016/S0885-3924(02)00677-2.
    1. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7:204–215. doi: 10.1111/j.1524-4733.2004.72252.x.
    1. Wong WS, Chow YF, Chen PP, Wong S, Fielding R. A longitudinal analysis on pain treatment satisfaction among Chinese patients with chronic pain: predictors and association with medical adherence, disability, and quality of life. Qual Life Res. 2015;24:2087–2097. doi: 10.1007/s11136-015-0955-1.
    1. Hirsh AT, Atchison JW, Berger JJ, et al. Patient satisfaction with treatment for chronic pain: predictors and relationship to compliance. Clin J Pain. 2005;21:302–310. doi: 10.1097/01.ajp.0000113057.92184.90.
    1. Conaghan PG, Serpell M, McSkimming P, Junor R, Dickerson S. Satisfaction, adherence and health-related quality of life with transdermal buprenorphine compared with oral opioid medications in the usual care of osteoarthritis pain. Patient. 2016;9:359–371. doi: 10.1007/s40271-016-0181-0.
    1. Timmerman L, Stronks DL, Huygen FJ. The relation between patients' beliefs about pain medication, medication adherence, and treatment outcome in chronic pain patients: a prospective study. Clin J Pain. 2019;35:941–947. doi: 10.1097/AJP.0000000000000760.
    1. Kravitz RL. Patients' expectations for medical care: an expanded formulation based on review of the literature. Med Care Res Rev. 1996;53:3–27. doi: 10.1177/107755879605300101.
    1. Lenderking WR. Brief reflections on treatment satisfaction. Value Health. 2005;8(Suppl 1):S2–5. doi: 10.1111/j.1524-4733.2005.00068.x.
    1. Gunaratne R, Pratt DN, Banda J, Fick DP, Khan RJK, Robertson BW. Patient dissatisfaction following total knee arthroplasty: a systematic review of the literature. J Arthroplasty. 2017;32:3854–3860. doi: 10.1016/j.arth.2017.07.021.
    1. Gimenez S, Armada B, Iturralde Iriso J, Ginel Mendoza L, Fernández-Morales B. Clinical management of patients with hip and knee osteoarthritis: patient satisfaction with treatment switch. Rheumatol Int. 2014;34:823–832. doi: 10.1007/s00296-013-2918-6.
    1. Dworkin RH, Jensen MP, Gould E, et al. Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events. J Pain. 2011;12:416–424. doi: 10.1016/j.jpain.2010.07.009.
    1. Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes—a means to understand. Curr Med Res Opin. 2008;24:3063–3072. doi: 10.1185/03007990802457040.
    1. Theiler R, Spielberger J, Bischoff HA, Bellamy N, Huber J, Kroesen S. Clinical evaluation of the WOMAC 3.0 OA Index in numeric rating scale format using a computerized touch screen version. Osteoarthr Cartil. 2002;10:479–81. doi: 10.1053/joca.2002.0807.
    1. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Rosner B. Fundamentals of biostatistics. 8. Boston, MA: Cengage Learning; 2015.
    1. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc. 1983;78:427–434.
    1. Bendel RB, Afifi AA. Comparison of stopping rules in forward 'stepwise' regression. J Am Stat Assoc. 1977;72:46–53.
    1. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137. doi: 10.1093/oxfordjournals.aje.a115101.
    1. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Stat Methodol. 1996;58:267–288.
    1. Schroeder LD, Sjoquist DL, Stephan PE. Understanding regression analysis: an introductory guide. Thousand Oaks, CA: SAGE; 2017.
    1. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613–619. doi: 10.1177/001316447303300309.
    1. Zhang L, Losin EAR, Ashar YK, Koban L, Wager TD. Gender biases in estimation of others' pain. J Pain. 2021;22:1048–59. doi: 10.1016/j.jpain.2021.03.001.
    1. Somers TJ, Wren AA, Shelby RA. The context of pain in arthritis: self-efficacy for managing pain and other symptoms. Curr Pain Headache Rep. 2012;16:502–508. doi: 10.1007/s11916-012-0298-3.
    1. Mihalko SL, Cox P, Beavers DP, et al. Effect of intensive diet and exercise on self-efficacy in overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. Transl Behav Med. 2019;9:227–235. doi: 10.1093/tbm/iby037.
    1. Nalamachu SR, Robinson RL, Viktrup L, et al. Multimodal treatment patterns for osteoarthritis and their relationship to patient-reported pain severity: a cross-sectional survey in the United States. J Pain Res. 2020;13:3415–3425. doi: 10.2147/JPR.S285124.
    1. Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. doi: 10.1136/bmj.h1225.

Source: PubMed

3
Subscribe